Cholesterol and RA

Published Online: Saturday, November 1, 2003

    During the early stages of rheumatoid arthritis (RA), cholesterol levels shift and can start causing plaque to build up in the arteries, suggest study findings published in the Annals of Rheumatic Disease (September 2003). Patients with RA often have levels of total cholesterol that are actually slightly below normal, noted the researchers.

    The problem is that high-density lipoprotein (HDL, or ?good?) cholesterol is decreased to a greater extent than is the total level of cholesterol. Therefore, the ratio of total cholesterol to HDL, known as the ?atherogenic index,? is usually >4, which raises the risk of atherosclerosis.

    The study included 47 participants with early active RA, 112 with long-standing RA, and 134 patients who were enrolled in a trial comparing treatment with sulfasalazine for RA with a combination regimen containing steroids. The researchers found that patients with established RA had total cholesterol levels that were slightly higher, compared with patients with early RA, who had total cholesterol levels that were on the low side of normal. All of the participants had HDL cholesterol levels that were below normal, and the lowest atherogenic index at the start of the study was 5.1.

    As for the participants in the treatment trial, both treatment groups showed an improvement in the atherogenic index. Steroidcontaining therapy produced a much more rapid improvement, compared with sulfasalazine. In the long run, however, harmful cardiovascular effects from steroids (eg, increased blood pressure and insulin resistance) would probably offset the improvement in atherosclerosis risk, the study authors said.

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues